NCT06408311View on ClinicalTrials.gov

Safety of ENC-201-CED ENCRT

PHASE1RecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions

Diabetes Mellitus, Type 1

Interventions

COMBINATION_PRODUCT

ENC-201-CED hPI

macro-encapsulated human primary islets

Trial Locations (2)

M5G 2C4

RECRUITING

UHN, Toronto

H4A 3J1

RECRUITING

McGill University Health Centre, Montreal

Sponsors

Lead Sponsor

All Listed Sponsors

collaborator

resCON Research

UNKNOWN

lead

Encellin

INDUSTRY